Fact CheckerSign in

NCT07800988Not yet recruiting

Vitis Intervention Trial in Substrate Metabolism

Acute Modulatory Role of Whole Grape Polyphenols on Room Calorimetry Derived Respiratory Exchange Ratio and Mitochondrial Function in Obesity

Source: ClinicalTrials.gov · Last updated 2 Sept 2026

Brief summary (registry, in English)

Obesity is associated with reduced metabolic flexibility (MetFlex), the capacity to shift between carbohydrate and lipid oxidation in response to nutrient availability. Grape polyphenols (resveratrol, catechins, quercetin, epicatechin) enhance fat oxidation and mitochondrial function in laboratory and animal studies, but whole grapes, rather than purified extracts, have not been tested for acute effects on MetFlex measured directly by whole-room calorimetry paired with mitochondrial function. This study integrates whole-room indirect calorimetry with high-resolution respirometry in peripheral blood mononuclear cells (PBMCs) to determine whether whole grape polyphenols shift the postprandial respiratory exchange ratio (RER) response to a high-fat meal and alter mitochondrial respiration, and whether responses differ by adiposity phenotype (lean vs. overweight/obesity).

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
18 Aug 2026
Start date
Sept 2026
Primary completion date
Jul 2027
Lead sponsor
University of Alabama at Birmingham
Diseases
Obesity
NCT number
NCT07800988

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From Sept 2026 to the primary completion date, Jul 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current smoking; drug or alcohol abuse
  • Hormone replacement therapy or medications known to affect metabolism
  • Current or prior bulimia nervosa, binge eating disorder, or anorexia nervosa

Other illness

  • Claustrophobia or psychiatric conditions that would make a 40-hour confined stay especially distressing or harmful
  • Grape allergy, or food allergies/intolerances precluding use of the metabolic kitchen
  • Any condition that, in the PI's opinion, would make participation unsafe or could interfere with conduct/interpretation of the study

Other

  • Weight instability, recent/active weight-loss attempts, or structured exercise initiation during the study
  • Pregnant or breastfeeding

Who the study is looking for

  • Men and women aged 25-60 years
  • BMI 18-24.9 kg/m² (lean phenotype, n=10) or BMI 25-40 kg/m² (overweight/obesity phenotype, n=10)
  • Low habitual grape consumption
  • Weight stable (no change \>5% in prior 6 months) and not actively attempting weight change
  • White blood cell count within normal limits

Age in the registry: 25 years to 60 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.